These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3225769)

  • 1. In vitro evaluation of a sustained-release veterinary peroral pellet preparation.
    Ritschel WA; Agrawala P; Kraeling M; Sathyan G; Berger K
    J Pharm Sci; 1988 Sep; 77(9):757-9. PubMed ID: 3225769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
    el-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1985 Feb; 74(2):161-4. PubMed ID: 3989685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
    Chung BH; Shim CK
    J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation.
    Amighi K; Timmermans J; Puigdevall J; Baltes E; Moës AJ
    Drug Dev Ind Pharm; 1998 Jun; 24(6):509-15. PubMed ID: 9876616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo-in vitro correlations with sustained-release theophylline preparations.
    Ritschel WA; Koch HP; Alcorn GJ
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):609-18. PubMed ID: 6513678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of in vitro dissolution studies of sustained release dosage form of theophylline and in vitro-in vivo evaluations in terms of correlations.
    Ertan G; Karasulu E; Ozgüney I; Karasulu Y; Apaydın S; Kantarcı G; Yurdasiper A; Ege MA
    Eur J Drug Metab Pharmacokinet; 2011 Dec; 36(4):243-8. PubMed ID: 21739190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability.
    Zhang Y; Huang Z; Omari-Siaw E; Lu S; Zhu Y; Jiang D; Wang M; Yu J; Xu X; Zhang W
    AAPS PharmSciTech; 2016 Apr; 17(2):339-49. PubMed ID: 26127010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the in-vitro dissolution method used for a new sustained-release theophylline pellet formulation.
    Dietrich R; Brausse R; Bautz A; Diletti E
    Arzneimittelforschung; 1988 Aug; 38(8A):1220-8. PubMed ID: 3190810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.
    Benedikt G; Steinijans VW; Dietrich R
    Arzneimittelforschung; 1988 Aug; 38(8A):1203-9. PubMed ID: 3190808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of shellac-coated sustained release pellet formulations.
    Farag Y; Leopold CS
    Eur J Pharm Sci; 2011 Mar; 42(4):400-5. PubMed ID: 21251975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.